Lin, Yung-Chang
Linkou Chang Gung Memorial Hospital
4 papers on CoChatORCID 0000-0002-2084-5348
Most cited papers
- Verified
Pembrolizumab alone or combined with chemotherapy versus chemotherapy as first-line therapy for advanced urothelial carcinoma (KEYNOTE-361): a randomised, open-label, phase 3 trial
Powles, T., Csőszi, T., Özgüroğlu, M., Matsubara, N., Géczi, L., Cheng, S. Y.-S., Fradet, Y., Oudard, S., Vulsteke, C., Morales Barrera, R., et al. (2021) · The Lancet Oncology
Bladder and Urothelial Cancer TreatmentsCancer Immunotherapy and Biomarkers
Cited by 643
- Verified
A multi-national, randomised, open-label, parallel, phase III non-inferiority study comparing NK105 and paclitaxel in metastatic or recurrent breast cancer patients
Fujiwara, Y., Mukai, H., Saeki, T., Ro, J., Lin, Y.-C., Nagai, S. E., Lee, K. S., Watanabe, J., Ohtani, S., Kim, S. B., et al. (2019) · British Journal of Cancer
Cancer Treatment and PharmacologyNanoparticle-Based Drug Delivery
Cited by 147
- Verified
Endotoxemia contributes to the immune paralysis in patients with cirrhosis
Lin, C.-Y., Tsai, I.-F., Ho, Y.-P., Huang, C.-T., Lin, Y.-C., Lin, C.-J., Tseng, S.-C., Lin, W.-P., Chen, W.-T., & Sheen, I.-S. (2007) · Journal of Hepatology
Liver Disease and TransplantationSepsis Diagnosis and Treatment
Cited by 145
- Verified
Xaluritamig, a STEAP1 × CD3 XmAb 2+1 Immune Therapy for Metastatic Castration-Resistant Prostate Cancer: Results from Dose Exploration in a First-in-Human Study
Kelly, W. K., Danila, D. C., Lin, C.-C., Lee, J.-L., Matsubara, N., Ward, P. J., Armstrong, A. J., Pook, D., Kim, M., Dorff, T. B., et al. (2024) · Cancer Discovery
Prostate Cancer Treatment and ResearchCancer Immunotherapy and Biomarkers
Cited by 125
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free